ఇమ్యునాలజీ: ప్రస్తుత పరిశోధన

నైరూప్య

The Janus-Faced Inflammasomes: Friend or Foe in Cancer

Dr. Matthew Wang

Cancer, a complex and multifactorial disease, continues to be a global health concern. Over the years, researchers have made significant strides in understanding the molecular mechanisms underlying cancer development and progression. Among these mechanisms, the inflammasome pathway has emerged as a fascinating area of investigation. Inflammasomes are multiprotein complexes that play a critical role in the regulation of inflammation and immunity. In recent years, mounting evidence has implicated inflammasomes in cancer, revealing their dual nature as both promoters and suppressors of tumorigenesis. This article aims to delve into the intricate relationship between inflammasomes and cancer, shedding light on their potential as therapeutic targets.